I am a senior genetic counselor in the Clinical Genetics Service at MSK Bergen. I trained as a genetic counselor in my hometown of Melbourne, Australia. Additionally, I have obtained a New Jersey genetic counselor license.
My primary research focus has been on the hereditary risk for gynecologic cancers. My other interests include the role of genetic counseling in the evaluation and care of women with an inherited predisposition to cancer and the pathology of inherited gynecologic cancers. I am an active member of the National Society of Genetic Counselors and the American Board of Genetic Counseling. I am part of the medical team for Project Hope for Ovarian Cancer Research and Education, and I serve on the editorial board of the Foundation for Women’s Cancer. I was an invited participant of the American College of Obstetricians and Gynecologists (ACOG) district II cancer genetics work group, which developed a hereditary cancer risk assessment slide set for all ACOG members.
I played a lead role in the MSK protocol Genomic Profiling in Cancer Patients, which includes both somatic testing of the tumor and testing normal tissue for germline (inherited) mutations. My involvement has allowed me to share my increasing knowledge about how tumor profiling can play a role in targeted therapy. I am also looking at the impact of multigene panel testing for both high-risk and low- to moderate-risk germline cancer predispositions in people with cancer and members of the cancer genetics community. I am currently working on a project about familial prostate cancer.